We are live on ! Find out more
Advent Capital Management

Advent Capital Management Portfolio holdings

AUM $4.46B Turnover 22.52%
1-Year Est. Return 0.73%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+0.73%
3 Year Est. Return
+2.9%
5 Year Est. Return
+0.82%
10 Year Est. Return
+4.72%
AUM
$6.36B
AUM Growth
–
Cap. Flow
+$812M
Cap. Flow %
12.77%
Top 10 Hldgs %
11.71%
Holding
554
New
89
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.29%
2 Consumer Discretionary 0.29%
3 Communication Services 0.16%
4 Healthcare 0.12%
5 Financials 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DISH
26
DELISTED
DISH Network Corp.
DISH
$1M 0.02%
+23,645
New +$921K
2013 Q2
0 quarters
SRC
27
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$848K 0.01%
+20,324
New +$974K
2013 Q2
0 quarters
TMUS icon
28
T-Mobile US
TMUS
$171B
$744K 0.01%
+30,000
New +$642K
2013 Q2
0 quarters
TOL icon
29
Toll Brothers
TOL
$12.3B
$666K 0.01%
+20,400
New +$689K
2013 Q2
0 quarters
NUAN
30
DELISTED
Nuance Communications, Inc.
NUAN
$624K 0.01%
+39,155
New +$667K
2013 Q2
0 quarters
SBRA icon
31
Sabra Healthcare REIT
SBRA
$4.92B
$597K 0.01%
+22,867
New +$660K
2013 Q2
0 quarters
EQIX icon
32
Equinix
EQIX
$96.3B
$462K 0.01%
+2,500
New +$520K
2013 Q2
0 quarters
REGN icon
33
Regeneron Pharmaceuticals
REGN
$81.2B
$450K 0.01%
+2,000
New +$466K
2013 Q2
0 quarters
IONS icon
34
Ionis Pharmaceuticals
IONS
$7.18B
$390K 0.01%
+14,500
New +$308K
2013 Q2
0 quarters
CELG
35
DELISTED
Celgene Corp
CELG
$386K 0.01%
+6,600
New +$397K
2013 Q2
0 quarters
HBIO icon
36
Harvard Bioscience
HBIO
$36.4M
$360K 0.01%
+10,095
New +$386K
2013 Q2
0 quarters
MNTG
37
DELISTED
M T R GAMING GROUP INC
MNTG
$305K ﹤0.01%
+91,054
New +$325K
2013 Q2
0 quarters
ILMN icon
38
Illumina
ILMN
$39.5B
$299K ﹤0.01%
+4,112
New +$263K
2013 Q2
0 quarters
CALY icon
39
Callaway Golf Company
CALY
$2.47B
$263K ﹤0.01%
+40,000
New +$266K
2013 Q2
0 quarters
FBIO icon
40
Fortress Biotech
FBIO
$62M
$258K ﹤0.01%
+2,000
New +$295K
2013 Q2
0 quarters
PPL.PRW icon
41
DELISTED
PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS
PPL.PRW
$233K ﹤0.01%
+4,290
New +$237K
2013 Q2
0 quarters
CHK icon
42
DELISTED
Chesapeake Energy Corporation
CHK
$185K ﹤0.01%
+48
New +$184K
2013 Q2
0 quarters
KRE icon
43
State Street SPDR S&P Regional Banking ETF
KRE
$3.31B
$169K ﹤0.01%
+5,000
New +$160K
2013 Q2
0 quarters
SUPN icon
44
Supernus Pharmaceuticals
SUPN
$2.22B
$145K ﹤0.01%
+22,500
New +$133K
2013 Q2
0 quarters
FLG.PRU icon
45
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$105M
$143K ﹤0.01%
+2,968
New +$145K
2013 Q2
0 quarters
HTWR
46
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$133K ﹤0.01%
+1,400
New +$127K
2013 Q2
0 quarters
FNM.PRS
47
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
$127K ﹤0.01%
+27,950
New +$127K
2013 Q2
0 quarters

Similar funds

Advent Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Advent Capital Management, which disclosed 554 positions worth $6.36B. Its ten largest holdings account for 12% of the portfolio.

Its largest position is Wells Fargo 7.5% Non Cumv Perp Conv: 58,729 shares worth $70.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, followed by Consumer Discretionary and Communication Services.

  • Advent Capital Management's largest Q2 2013 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 58,729 shares worth $70.1M.
  • Advent Capital Management's ten largest holdings make up 12% of its $6.36B portfolio in Q2 2013.
  • Advent Capital Management disclosed 554 positions in Q2 2013, its first 13F filing on record.

Based on Advent Capital Management's 13F filing for Q2 2013, filed 8 Oct 2013.